Bank of New York Mellon Corp Invests $1.34 Billion in Intuitive Surgical, Inc. $ISRG

Key Points

• Bank of New York Mellon acquired 3.36 million Intuitive Surgical shares worth approximately $1.34 billion, representing about 0.95% of the company. Institutional investors collectively own 83.64% of ISRG.
• Intuitive Surgical reported strong quarterly results, with revenue up 18.4% year over year to $2.89 billion and EPS of $2.80, beating analyst expectations of $2.48.
• Despite a broadly favorable analyst consensus of “Moderate Buy,” shares have fallen 5.8% and recently traded at $374.48. Investors remain concerned about the company’s cautious procedure-growth outlook, tariff-related margin pressure and ongoing insider selling.

Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,358,863 shares of the medical equipment provider's stock, valued at approximately $1,335,753,000. Bank of New York Mellon Corp owned approximately 0.95% of Intuitive Surgical at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of ISRG. Laurel Wealth Advisors LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth approximately $31,000. Turning Point Benefit Group Inc. increased its stake in Intuitive Surgical by 833.3% in the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider's stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Motiv8 Investments LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $34,000. Oakworth Capital Inc. lifted its position in shares of Intuitive Surgical by 281.2% during the 4th quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider's stock worth $35,000 after buying an additional 45 shares during the last quarter. Finally, Main Street Group LTD purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 5.8%

Shares of ISRG stock opened at $374.48 on Friday. The stock's 50-day moving average price is $389.12 and its 200 day moving average price is $437.10. The stock has a market capitalization of $132.30 billion, a PE ratio of 42.90, a price-to-earnings-growth ratio of 2.88 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the company posted $1.81 earnings per share. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. Analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the company's stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm's stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares of the company's stock, valued at $498,271,600. This trade represents a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,206 shares of company stock worth $6,986,510 in the last 90 days. Corporate insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Royal Bank Of Canada dropped their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday, July 13th. Robert W. Baird dropped their price objective on Intuitive Surgical from $525.00 to $500.00 and set an "outperform" rating on the stock in a report on Friday, July 17th. Mizuho set a $500.00 target price on Intuitive Surgical and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. BMO Capital Markets reissued an "outperform" rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, Bank of America decreased their target price on Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus price target of $508.68.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical’s robotic-assisted surgery platform continues to attract investor interest, supported by the long-term shift toward minimally invasive procedures and recurring revenue from instruments, accessories and services. Intuitive Surgical robotic surgery platform article
• Positive Sentiment: The company is expanding its manufacturing footprint in Asia-Pacific with a new Penang facility. The plant should increase production capacity and position ISRG to serve rising regional demand for robotic surgery systems. Intuitive Surgical expands manufacturing in Asia-Pacific
• Positive Sentiment: Recent quarterly results showed revenue of $2.89 billion, up 18.4% year over year, while adjusted EPS of $2.80 exceeded the $2.48 consensus estimate. Procedures increased about 16%, and 468 da Vinci systems were placed, demonstrating continued demand. Analysts retain a broadly favorable view, with a consensus “Moderate Buy” rating and target prices materially above recent trading levels.
• Neutral Sentiment: Institutional activity was mixed in the latest quarter: 1,070 investors added ISRG shares while 1,306 reduced positions. Large additions by Invesco, JPMorgan and Arrowstreet were offset by notable reductions from T. Rowe Price, FMR and Winslow Capital, suggesting divided sentiment rather than a clear institutional trend.
• Negative Sentiment: Investors remain concerned that Intuitive Surgical maintained its 2026 da Vinci procedure-growth forecast at approximately 13.5%–15.5%, with results expected near the midpoint, despite the strong quarter. Management also expects tariffs to reduce 2026 non-GAAP gross margin by about 1% of revenue, with additional risk if tariffs rise. These factors have contributed to post-earnings valuation pressure. Intuitive Surgical cautious outlook article
• Negative Sentiment: Insider-trading data shows repeated open-market sales and no purchases over the past six months. EVP Mark Brosius’s recent sales totaled roughly $30,000 each and were made under a pre-arranged Rule 10b5-1 plan, limiting their significance individually, but the broader pattern may reinforce investor caution. Intuitive Surgical insider selling article

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source